Atlas Trials

Study of Meninigococcal Conjugate Vaccine Containing Serogroups A,C,Y,W and X (MCV5) in Healthy Adults

Clinical trial NCT02810340 · COMPLETED

Trial details

NCT number
NCT02810340
Sponsor
PATH
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Meningococcal Vaccines
Start date
2016-08-01
Primary completion
2017-10-13
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.